The abilities of clioquinol in the therapy of dermatoses complicated by secondary infection

Lavrov A.A.

Tsentr teoreticheskikh problem fiziko-khimicheskoĭ farmakologii RAN

Nevozinskaia Z.A.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Sorkina I.L.

Dermatovenerological Dispensary No 16

Korsunskaia I.M.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

The abilities of clioquinol in the therapy of dermatoses complicated by secondary infection

Authors:

Lavrov A.A., Nevozinskaia Z.A., Sorkina I.L., Korsunskaia I.M.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2013;11(6): 108‑111

Downloaded: 17

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Lavrov AA, Nevozinskaia ZA, Sorkina IL, Korsunskaia IM. The abilities of clioquinol in the therapy of dermatoses complicated by secondary infection. Russian Journal of Clinical Dermatology and Venereology. 2013;11(6):108‑111. (In Russ.)

Close metadata

The paper considers the treatment of secondary infection-complicated dermatoses, by using topical glucocorticosteroids in combination with antibiotics and antimycotics. Combined topical glucocorticosteroids, such as Lorinden C, has been found to lead to successful elimination of secondary infection.

Keywords:

dermatoses

allergic dermatitis

secondary infection

topical combined glucocorticosteroids

Lorinden C

Authors:

Lavrov A.A.

Tsentr teoreticheskikh problem fiziko-khimicheskoĭ farmakologii RAN

Nevozinskaia Z.A.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Sorkina I.L.

Dermatovenerological Dispensary No 16

Korsunskaia I.M.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

List of references:

Shibaeva E.V., Pyshkina E.I. Naruzhnaya terapiya infitsirovannykh dermatozov: adekvatnyi podkhod k vyboru preparata. Effekt farmakoter 2013; 8: 10-15.
Simor A.E., Stuart T.L., Louie L., Watt C., Ofner-Agostini M., Gravel D. et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007; 51: 3880-3886.
McDonnell G., Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-179.
Mao X., Schimmer A.D. The toxicology of clioquinol. Toxicol Lett 2008; 182: 1-6.
Susceptibility testing (Swedish Reference Group for Antibiotics). 2004. http://www.srga.org/RAFMETOD/BASMET.HTM
Karami N., Alsterholm M., Faergemann J. In vitro activity of chlorhexidine and pentane-1,5-diol and their combination on Candida albicans, Staphylococcus aureus and Propionibacterium acnes. Acta Dermatol Venereol 2009; 89: 514-515.
Eifler-Bollen R., Fluhr J.W. Antimikrobiell wirksame Magistralrezepturen. Stellenwert in der Praxis und kritische Anmerkungen. Hautarzt 2005; 56: 752-758.
Faergemann J., Hedner T., Larsson P. The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage? Acta Dermatol Venereol 2005; 85: 203-205.

Close metadata